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S100A8/A9 (calprotectin), which is released by neutrophils under inﬂammatory conditions, has the capacity to induce apoptosis in
various cells. We previously reported that S100A8/A9 induces apoptosis of EL-4 lymphoma cells via the uptake of extracellular zinc
in a manner similar to DTPA, a membrane-impermeable zinc chelator. In this study, S100A8/A9-induced apoptosis was examined
in several cell lines that are weakly sensitive to DTPA, suggesting S100A8/A9 is directly responsible for apoptosis in these cells.
Since zinc inhibits apoptosis of MM46, one of these cells, the regulation by zinc of the capacity of S100A8/A9 to bind MM46 cells
was studied. When MM46 cells were incubated with S100A8/A9 in standard or zinc-depleted medium, the amounts of S100A8/A9
bound to cells was markedly lower at 3h than at 1h. In contrast, when MM46 cells were incubated with S100A8/A9 in the presence
of high levels of zinc, binding to cells was the same at 1 and 3h. When the cells were permeabilized with saponin prior to analysis, a
larger amount of cell-associated S100A8/A9 was detected at 3h. The amount was further increased in cells treated with chloroquine,
suggesting that S100A8/A9 was internalized and degraded in lysosomes. Although it has been reported that S100A8/A9 binds to
heparan sulfate on cell membranes, the amount of S100A8/A9 bound to MM46 cells was not reduced by heparinase treatment, but
was reduced by trypsin treatment. These results suggest that S100A8/A9 induces apoptosis by direct binding to MM46 cells, and
that this activity is regulated by zinc.
INTRODUCTION
S100A8 and S100A9 are calcium- and zinc-binding
proteins from the S100 protein family that are abundant
in the cytosol of neutrophils [1, 2]. These proteins are
released from neutrophils as a heterodimeric complex,
S100A8/A9, under inﬂammatory conditions. The com-
plex is also known as calprotectin, since it showed anti-
fungal activity [3]. The smaller 8kd component, S100A8,
has also been termed migration inhibitory factor-related
protein(MRP)-8andcalgranulinA,whilethelarger14kd
component, S100A9, has been termed MRP14 and cal-
granulin B [4, 5]. It has been reported that amounts of
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S100A8/A9 in blood or extracellular body ﬂuid are in-
creased under many pathological conditions, for instance,
rheumatoid arthritis [6], inﬂammatory bowel diseases
[7], viral or microbial infections [8, 9], tumors [10], and
many inﬂammatory conditions [11]. Notably, abscess ﬂu-
ids contain more than 1mg/mL of the protein complex
[12].
Although S100A8/A9 is abundant under many in-
ﬂammatory conditions, the physiological role of this fac-
tor is not fully understood. Proposed extracellular ac-
tivities of the protein complex include antifungal activ-
ity [13, 14] and chemotactic activity against neutrophils
[15]. On the other hand, we reported that S100A8/A9 in-
duced apoptosis in tumor cells [16, 17] and normal ﬁ-
broblasts [18]. Therefore, it is proposed that S100A8/A9
is a neutrophil-derived eﬀector acting against tumor cells
and is a factor regulating inﬂammatory processes via
apoptosis-inducing activity [19].
Zinc ions are a regulator for the antifungal activity of
S100A8/A9: chelation of zinc by the protein complex is
speculated to be the mechanism of the fungistatic activity
[14, 20, 21]. We found that the apoptosis-inducing activ-
ity of S100A8/A9 is inhibited in the presence of zinc ions2005:5 (2005) Calprotectin Binding to Tumor Cells 281
[17]. By contrast, the activity was augmented in medium
deprived of divalent cations (other than Ca++ and Mg++)
[18]. We also reported that the protein complex induces
apoptosis of EL-4 mouse lymphoma cells via exclusion of
extracellular zinc in a manner similar to a membrane-
impermeable zinc chelator, DTPA [22]. However, there
are several reports dealing with the binding capacity of
S100A8 and/or S100A9 and the binding molecules on
diﬀerent types of cells: S100A9 and S100A8/A9 report-
edly bind heparan sulfate on the surface of endothelial
cells [23], and S100A8/A9 binds carboxylated glycans on
endothelial cells [24]. It was also proposed that a scav-
enger receptor, CD36, binds the complex of S100A8/A9
and arachidonic acid [25]. Moreover, the receptor for ad-
vanced glycated end product (RAGE) reportedly binds
S100B, S100A1, and S100A12 proteins [26, 27], although
it is unknown whether RAGE is a general receptor for the
members of the S100 protein family.
Recently, it was proposed that S100A8/A9 induced
apoptosis in colon cancer cell lines via the exclusion of
zinc from the target cells or some unknown mechanism
[28]. Since S100A8/A9 has a very broad target speciﬁcity
(we have not encountered any cell lines that are resis-
tant to the apoptosis-inducing activity of S100A8/A9),
S100A8/A9 may induce apoptosis by a mechanism that
requires the binding of the factor to target cells, in
addition to the mechanism of extracellular zinc exclu-
sion.
In this paper, we examined the cell death-inducing ac-
tivities of S100A8/A9 and the zinc chelator DTPA in ﬁve
tumor cell lines, and observed that S100A8/A9 induced
cell death of DTPA-sensitive cell lines as well as three cell
lines including MM46 mouse mammary carcinoma cells,
which are resistant to DTPA. Further studies showed that
theactionofS100A8/A9againstMM46cellswasinhibited
by zinc. The eﬀect of zinc on the binding of S100A8/A9
to MM46 cells suggest a novel mechanism in which zinc-
regulated S100A8/A9 association with target cells induces
apoptosis.
MATERIALS AND METHODS
Reagents
Diethylenetriaminepentaacetic acid (DTPA), NNN -
N -tetrakis-(2-pyridylmethyl) ethylenediamine (TPEN),
chloroquine, heparinase I, and sodium heparin were pur-
chased from Sigma (St Louis, Mo). FlouZin-3,AM was
from Molecular Probes (Eugene, Ore). Trypsin (1:250)
wasfromGIBCO(GrandIsland,NY).Mousemonoclonal
anti-human MRP8 (S100A8) and anti-human MRP14
(S100A9) antibodies were from BMA (Augst, Switzer-
land). Goat FITC-conjugated anti-mouse IgG antibody
was purchased from Santa Cruz Biotechnology (Santa
Cruz, Calif). ZnSO4·7H2O, Saponin, NaN3, and other
chemicalswerefromWakoPureChemicalIndustries(Os-
aka, Japan).
RecombinanthumanMRP8andMRP14
Recombinant human S100A8 and S100A9 were pre-
pared as described previously [22]. Brieﬂy, competent
Escherichia coli strain BL21 (DE3) cells (Novagen, Madi-
son, Wiss) were transformed using the vector pET1120-
MRP8(S100A8)wt or pET1120-MRP14(S100A9)wt [29].
T h et r a n s f o r m e dc e l l sw e r eg r o w ni n( 2 × YT) medium
supplemented with 100µg/mL ampicillin for 24h, and
produced the proteins as inclusion bodies. The harvested
c e l l sw e r es o l u b i l i z e dw i t hB - P E RB a c t e r i a lP r o t e i nE x -
traction Reagent (PIERCE, Rockford, Ill). The inclusion
bodies were solubilized with Inclusion Body Solubiliza-
tion Reagent (PIERCE), and the proteins were refolded
according to the manufacturer’s directions. The pro-
teins were puriﬁed by reverse-phase column chromatog-
raphy (Resource RPC, Amersham Pharmacia, Bucking-
hamshire, UK) furnished in a BioLogic HR system (BIO-
RAD, Hercules, Calif), followed by UNO-Q anion ex-
change chromatography (BIO-RAD).
Celllines
EL-4 mouse thymoma, MOLT-4 human leukemia,
and MH134 mouse hepatoma cell lines were maintained
in RPMI 1640 medium supplemented with 5% fetal calf
serum (FCS). MM46 spontaneous mammary carcinoma
cells and Ehrlich carcinoma cells were passaged weekly in
the peritoneal cavity of male C3H/He mice and ddY mice
(Japan SLC Inc, Shizuoka, Japan), respectively.
MTTassay
The MTT assay was used to evaluate cell death. Each
cell line (1 × 104 cells/well) was cultured with test sam-
ples in 96-well microtest plates (Iwaki, Chiba, Japan) with
200µL of RPMI1640 medium supplemented with 100U
of penicillin, 60µg/mL kanamycin, and 5% FCS (here-
after referred to as the standard medium) at 37◦Ci nah u -
midiﬁed atmosphere of 5% CO2 in air. After the appro-
priate periods, 25µL of 3-(4,5-dimetyl-2-thiazolyl)-2,5-
diphenyl -2H-tetrazolium bromide (MTT, 5mg/mL) was
added to the cultures and the plates were incubated for an
additional 3h. Then, 150µL of the supernatant was dis-
carded, 100µL of acidiﬁed isopropanol (0.04N HCl in 2-
propanol) was added to each well, and the optical density
(595nm) was measured with a microplate reader (Multi-
scanMS-UV,Labsystems,Basingstoke,UK).Dataarerep-
resented as the mean ± SD of triplicate estimations.
Divalentcation-depletedmedium
To prepare divalent cation (other than Ca++ and
Mg++)-depleted medium, 100mLof RPMI-1640medium
containing 5% FCS that had been extensively dialyzed
against phosphate-buﬀered saline (PBS) was applied to a
Chelex 100 column (Bio-Rad, 1.0×20cm). Then, 500µM
CaCl2 and 400µMM g C l 2 were added to supplement the
calciumandmagnesium.Thismediumisreferredtohere-
after as the divalent cation-depleted medium.282 Yuichi Nakatani et al 2005:5 (2005)
Intracellularzincconcentration
EL-4 or MM46 cells (1 × 105 cells/well) were incu-
bated in 24-well plates with 1mL of the standard medium
with samples at 37◦C for 6h. After 3 washes with PBS, the
cells were treated with 1mM FlouZin-3,AM for 30min at
37◦C. The cells were washed 3 times with PBS and ana-
lyzed using a FACSscan ﬂow cytometer (Beckman Coul-
ter, Philadelphia, Pa).
S100A8/A9bindingassay
EL-4 or MM46 cells (1 × 105 cells/well) were incu-
bated in 24-well plates with a speciﬁc concentration of
S100A8/A9 sample for 1 or 3h at 37◦Ci n5 %C O 2 in
air, unless otherwise indicated. The cells were washed 3
times with PBS containing 2% FCS, and were treated with
anti-S100A9 antibody at a dilution of 1:100 for 30min on
ice. The cells were washed 3 times with PBS (2% FCS),
and treated with the secondary FITC-conjugated anti-
mouse IgG antibody at a dilution of 1:100 for an addi-
tional 30min on ice. The ﬂuorescence intensity associ-
ated with cells was analyzed with a FACSscan ﬂow cy-
tometer. The morphology of the cells was observed with
a ﬂuorescence microscope (Nikon, Eclipse, TE2000U,
Tokyo, Japan), after being ﬁxed with 4% formaldehyde
and treated with anti-S100A9 antibody and the secondary
FITC-conjugated antibody as above.
To estimate the cell-associated amount of S100A8/A9,
whichincludesS100A8/A9inintracellularcompartments,
the treated cells were ﬁxed with 4% formaldehyde after
three washes with PBS, and treated with PBS contain-
ing 0.5% saponin and 1% bovine serum albumin for 10
minatroomtemperature.Afterthat,thecellsweretreated
with anti-S100A9 antibody and the FITC-conjugated sec-
ondary antibody as described above.
TrypsinandheparinasetreatmentsofMM46cells
MM46 cells were treated with 0.25% trypsin or
4U/mL heparinase I at 37◦Cf o r5o r6 0m i n ,r e s p e c t i v e l y .
After the digestion, the cells were washed three times with
PBS, and used as targets for the binding of S100A8/A9.
RESULTS
CytotoxicityofS100A8/A9andDTPAagainst
severalcelllines
ToexaminewhetherthecytotoxicityoftheS100A8/A9
heterodimer is solely due to exclusion of extracellular zinc
by chelation, the cytotoxic activity of recombinant hu-
man S100A8/A9 against several tumor cell lines was com-
pared with that of a membrane-impermeable zinc chela-
tor, DTPA, and a membrane-permeable zinc chelator,
TPEN. Consistent with our previous report, S100A8/A9,
as well as DTPA alone, induced the death of EL-4 cells
at 40h of culture (Figure 1a). S100A8/A9 and TPEN eﬃ-
ciently induced loss of viability of MOLT-4 cells, while the
eﬀect of DTPA on the cells was weak at 40h. On the other
hand, S100A8/A9 and TPEN at 5µM showed cytotoxicity
against MM46 cells, MH134 cells, and Ehrlich carcinoma
cells at 24h, whereas DTPA did not show any cytotoxic-
ity. Even at 100µM, DTPA did not reduce the viability of
MM46 cells at 24h (data not shown).
SincewepreviouslyreportedthattheMM46celldeath
induced by S100A8/A9 is due to apoptosis and the time
course of the apoptotic induction of this cell type was
well characterized [30], we used MM46 cells in the sub-
sequent experiments. We also found that S100A8/A9 in-
duced activation of caspase-3 and mitochondrial perme-
ability transition in MM46 cells (unpublished observa-
tions). Figure 1b shows the time-course of the cytotoxic
activities of S100A8/A9 and DTPA against MM46 cells.
S100A8/A9 exerted full cytotoxicity in MM46 cells from
24h. In contrast, DTPA did not show any cytotoxicity at
24h. It took 3 days for DTPA to fully induce cell death,
suggesting that S100A8/A9 induces MM46 cell death via a
fundamentally diﬀerent mechanism than that of DTPA.
We previously reported that the S100A9 homod-
imer induced EL-4 cell death at 10µM, while the activ-
ity of the S100A8 homodimer is very weak: it showed
marginal cytotoxicity even at 40µM. On the other hand,
the S100A8/A9 complex has more potent activity against
EL-4 cells: the onset of cytotoxicity occurred at 5µM
(Figure 1a and [22]). Because S100A8/A9-induced apop-
tosis of MM46 cells may involve a diﬀerent mechanism
from that in EL-4 cells, the eﬀects of the individual sub-
units on MM46 cells were also investigated. Figure 3a
showsthatneitherS100A8norS100A9ontheirownshow
cytotoxicity against MM46 cells.
To examine whether MM46 cells are less sensitive
than EL-4 cells to zinc, the intracellular zinc concentra-
tions of the two cell lines after treatment with S100A8/A9,
DTPA, or TPEN were compared in a FACS analysis us-
ing FlouZin-3,AM as a probe. As shown in Figure 2,
membrane-impermeable DTPA induced a reduction in
the intracellular zinc concentration of MM46 cells at 6h.
T h ed e g r e eo fr e d u c t i o nw a ss i m i l a rt ot h a to b s e r v e df o r
the membrane-permeable TPEN, and the patterns of re-
duction were indistinguishable from those of EL-4 cells.
The eﬀect of S100A8/A9 on the intracellular zinc was
comparable to that of DTPA and TPEN, in both EL-4 cells
and MM46 cells.
The data in Figure 1 indicates that MM46 cells are
more resistant to the shortage of intracellular zinc than
EL-4 cells. This suggests that S100A8/A9 can induce cell
deathviaamechanismotherthanzincexclusion,andthat
direct binding of S100A8/A9 to MM46 cells is involved.
BindingofS100A8/A9toMM46cells
We next analyzed the binding of S100A8/A9 and
the homodimers to MM46 cells using ﬂow cytometry.
Monoclonal antibodies against S100A8 or S100A9 were
used as the ﬁrst antibodies, followed by secondary FITC-
conjugated anti-mouse IgG antibody. After demonstrat-
ingthatthebindingofS100A8/A9toMM46cellscouldbe
detected by either anti-S100A8 or anti-S100A9 antibody2005:5 (2005) Calprotectin Binding to Tumor Cells 283
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Figure 1. Cell death-inducing activity of recombinant human S100A8/A9 complex, DTPA and TPEN against various cell lines. (a)
The indicated cell lines were cultured with S100A8/A9 (•), DTPA (), or TPEN () for 24h (MM46 cells, MH-134 cells, and Ehrlich
cells) or 40h (EL-4 cells and MOLT-4 cells). (b) Kinetics of induction of MM46 cell death by S100A8/A9 and DTPA. MM46 cells were
cultured without () or with 10µM S100A8/A9 (•)o r1 0µMD T P A( ) for the indicated periods. The viability of each cell line was
evaluated by MTT assay. Bars represent standard deviation.284 Yuichi Nakatani et al 2005:5 (2005)
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Figure 2. Reduction of the intracellular zinc concentration of (a) MM46 cells and (b) EL-4 cells treated with S100A8/A9 complex,
DTPA, or TPEN. The cells were cultured without (solid line) or with (dotted line) 5µM S100A8/A9, 5µMD T P A ,o r5µMT P E N
for 6 hours, respectively. The intercellular zinc concentration was measured using Zn-speciﬁc ﬂuorescence probe, FluoZin3,AM as
described in “materials and methods.”
(Figure 3b), it was decided to use the anti-S100A9 anti-
body for the detection of the complex in all subsequent
assays. The binding assays were performed at 37◦C; a con-
trol experiment at 4◦C gave quite similar histograms at
1h (data not shown). Remarkably, the S100A9 homod-
imer showed a similar degree of binding in the assay as
the S100A8/A9 complex (Figure 3b), in spite of its lack of
cytotoxic eﬀect on MM46 cells. The S100A8 homodimer
showed a lesser degree of binding. We note that the lower
activity of S100A8 may be caused by its relative instability
compared to S100A9 and the S100A8/A9 complex.
Adose-responsecurvewasdeterminedforS100A8/A9
binding at 1h,andwasdepicted inFigure3c.Theamount
of S100A8/A9 increased in a dose-dependent manner up
to 5µM, but then markedly decreased at 10µMa n db e -
yond.
ZincregulationofthebindingofS100A8/A9
totumorcells
We previously reported that the cytotoxic activity of
S100A8/A9 against EL-4 cells is inhibited by zinc, and that
S100A8/A9-induced cell death occurs at lower concentra-
tions in divalent cation-depleted (other than Ca++ and
Mg++)m e d i u m[ 16, 17, 18, 22]. Although the cytotoxic
eﬀect of S100A8/A9 on MM46 cells observed at 24h ap-
pears to not be directly induced by exclusion of zinc in the
medium (Figure 1), S100A8/A9 cytotoxicity was moder-
ately and completely inhibited by the presence of 2.5µM
and 5µM zinc, respectively (Figure 4a). As observed for
EL-4 cells, the dose-response curve shifted to lower con-
centration ranges in the divalent cation-depleted medium
(Figure 4b). These data suggest that zinc modulates the
cytotoxic activity of S100A8/A9.2005:5 (2005) Calprotectin Binding to Tumor Cells 285
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Figure 3. (a) Apoptosis-inducing activity of S100A8, S100A9, and S100A8/A9 against MM46 cells. Cells were cultured with diﬀerent
concentrations of S100A8/A9 complex (•), S100A8 (), or S100A9 () for 24 hours. Cell viability was estimated by MTT assay. Bars
represent standard deviation. (b) Binding proﬁle of S100A8/A9 complex, S100A8, or S100A9 to MM46 cells. The cells were incubated
with (gray line) or without (black line) 5µM S100A8, 5µM S100A9, or 5µM S100A8/A9 for 1h, respectively. After the incubation,
the cells were washed and treated with anti-S100A8 antibody or anti-S100A9 antibody, followed by FITC-conjugated anti-mouse IgG
antibody, and analyzed as described in “materials and methods.” (c) Dose-response relationship of the binding of S100A8/A9. MM46
cells were incubated with the indicated concentrations of S100A8/A9 for 1h and the binding is expressed as the geometric mean
ﬂuorescence intensity of 10000 cells.286 Yuichi Nakatani et al 2005:5 (2005)
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Figure 4. Zinc inhibits apoptosis-inducing activity of S100A8/A9 complex against MM46 cells. (a) MM46 cells were cultured without
(open column) or with (ﬁlled column) 5µM S100A8/A9 in the presence of the indicated concentrations of zinc sulfate for 24h. (b)
Augmentation of the apoptosis-inducing activity of S100A8/A9 in divalent cation-depleted medium. MM46 cells were cultured with
10µM S100A8/A9 in the standard medium (•) or divalent cation-depleted medium () for 24h and the viability was evaluated by
MTT assay. Bars represent standard deviation.
To check the eﬀect of zinc on the association of
S100A8/A9 with MM46 cells, we measured binding
in the presence of various concentrations of zinc. At
10µM S100A8/A9, the amount of protein that binds to
MM46 cells at 1h was very small in the divalent cation-
depleted medium, but binding was augmented in a dose-
dependent manner in the presence of zinc (Figure 5a).
We next examined the kinetic changes of the bind-
ing of S100A8/A9 to MM46 cells. A S100A8/A9 concen-
tration of 10µM was used because this concentration has
been shown to induce apoptosis in standard medium. As
shown in Figure 5b, the amounts of S100A8/A9 in the
divalent cation-depleted medium at 30min and 1h were
much smaller than the amounts in the standard medium,
and decreased markedly at 3h. In the standard medium,
binding of the protein complex was observed at 30min,
and was slightly increased at 1h, but the binding was
much decreased at 3h. Interestingly, the binding of the
S100A9 homodimer detected at 1h was not decreased at
3h(Figure 5c).
To assess whether zinc aﬀects the kinetic changes in
the binding of S100A8/A9 in standard medium, the bind-
ingoftheproteincomplexwasanalyzedinthepresenceof
20µM zinc sulfate, conditions under which the cytotoxi-
city of S100A8/A9 is completely inhibited. Unexpectedly,
binding at 3h in the presence of excess zinc was not de-
creased, but rather, the amount in the MM46 cells at 3h
was increased (Figure 5b). Morphologically, several dots
of ﬂuorescence were observed on the cells at 1h in the ab-
sence and the presence (stoichiometric or excess) of zinc,
suggesting that S100A8/A9 forms aggregated structures
on the cell membrane.
InEL-4cells,inwhichapoptosisappearstobeinduced
via the exclusion of zinc by S100A8/A9, the initial binding
of protein complex to cells was markedly decreased at 3h
(Figure 5d). The binding of S100A8/A9 to EL-4 cells was
increased in the presence of 20µM zinc sulfate. Thus, as
in MM46 cells, the addition of zinc enables S100A8/A9 to
remain bound to EL-4 cells at 3h.
InternalizationofS100A8/A9inMM46cells
We have noted that the binding of S100A8/A9 to
cells is reduced during the incubation in the standard
medium or in the divalent cation-depleted medium. To
elucidate the mechanism for this phenomenon, we ex-
amined whether the protein complex is internalized by
MM46 cells. For this, MM46 cells treated with S100A8/A9
were ﬁxed and permeabilized with saponin, and the
cell-associated S100A8/A9 was detected using the anti-
S100A9 antibody. At 1h of incubation, the amount of
cell-associated S100A8/A9 in the permeabilized cells was
almost the same as that in the unpermeabilized cells.
The amount detected without saponin treatment was
markedly reduced at 3h. However, the diﬀerence in the
amountinthepermeabilizedcellsbetween1hand3hwas
very slight (Figure 6a), suggesting that S100A8/A9 was in-
ternalized within the cells during 1–3h.
Next, to check the possibility that the internal-
ized S100A8/A9 molecules were degraded in lysosomes,
MM46 cells were treated with S100A8/A9 in the presence2005:5 (2005) Calprotectin Binding to Tumor Cells 287
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Figure 5.ProﬁleofthebindingofS100A8/A9toMM46cellsindivalentcation-depletedmedium,instandardmediumorthepresence
of excess zinc. (a) Enhancement of the binding of S100A8/A9 to MM46 cells by zinc. The cells were incubated with 5µM S100A8/A9
in the divalent cation-depleted media supplemented with 1.25µM( r e d ) ,2 . 5µM( b l a c k ) ,5µM( b l u e ) ,1 0µM (green), or 20µM( y e l -
low) zinc sulfate at 37◦C for 1h. (b) Kinetic changes in the binding proﬁle of S100A8/A9. MM46 cells were incubated with 10µM
S100A8/A9 for 30min (blue), 1h (green), or 3h (red) at 37◦C in the deﬁned divalent cation medium (upper panel), in the stan-
dard medium (middle panel), or in the standard medium with 20µM zinc sulfate (lower panel). Insets: morphological appearance
of MM46 cells incubated with 10µM S100A8/A9 for 1h in the deﬁned divalent cation medium (upper), in the standard medium
(middle), or in the standard medium with 20µM zinc sulfate (lower). The binding of S100A8/A9 on the ﬁxed cells was visualized as
described in “materials and methods.” (c) Binding of S100A9 to MM46 cells. The cells were incubated at 37◦C with 10µM S100A9 for
1h (green) or 3h (blue). (d) Changes in the proﬁle of binding of S100A8/A9 to EL-4 cells. EL-4 cells were incubated in the standard
medium (upper panel) or 20µM zinc sulfate (lower panel) with 10µM S100A8/A9 at 37◦C for 30min (blue), 1h (green), or 3h (red).
(a), (b), (c), and (d) black line: histograms of the control cells which were incubated without any sample for 1h in the respective
medium.288 Yuichi Nakatani et al 2005:5 (2005)
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Figure 6. Detection of intracellular S100A8/A9 complex in MM46 cells. (a) MM46 cells were treated at 37◦C without (black line),
or with 10µM S100A8/A9 for 1h (black histogram) or 3h (gray histogram). In the upper panel, the treated cells were washed and
S100A8/A9 binding was immediately analyzed with anti-S100A9 antibody. In the middle panel, the treated cells were washed, ﬁxed,
and permeabilized with saponin, and the cell-associated S100A8/A9 was detected with anti-S100A9 antibody. In the lower panel,
the cells were incubated with S100A8/A9 in the presence of 100µM chloroquine, and after that, the cells were washed, ﬁxed, and
permeabilized with saponin, and the cell-associated S100A8/A9 was detected with anti-S100A9 antibody. (b) Eﬀects of sodium azide
on the changes in the binding proﬁle of S100A8/A9. The cells were incubated at 37◦C without (black line) or with S100A8/A9 plus
50mM sodium azide for 1h (black histogram) or 3h (gray histogram). After that, the cells were washed and S100A8/A9 binding was
immediately analyzed with anti-S100A9 antibody. (c) Eﬀect of sodium azide on the apoptosis-inducing activity of S100A8/A9. MM46
cells were cultured with (ﬁlled column) or without (open column) 10µM S100A8/A9 for 24h. Sodium azide (50mM) was present in
the culture during the indicated periods. Bars represent SD.
of chloroquine, a lysosome enzyme inhibitor, and the
cells were ﬁxed, permeabilized, and analyzed. The cell-
associated S100A8/A9 at 1h incubation was little aﬀected
by chloroquine treatment, and the amount of S100A8/A9
at 3h was slightly larger. Importantly, the amount at 3h
was much greater than that observed for permeabilized
MM46 cells not treated with chloroquine (Figure 6a).
These results suggest that some of the protein complex
is degradated in lysosomes after being internalized by the
cells.
S100A8/A9 binding was further characterized by ex-
amining the eﬀect of sodium azide, an inhibitor of energy
metabolism, on the change in the amount of bound
S100A8/A9 during the incubation. Figure 6b shows that
the amount of S100A8/A9 bound at 1h was not decreased
at 3h in the presence of sodium azide, suggesting that
an energy-dependent process is responsible for the in-
ternalization of S100A8/A9. Since sodium azide inhibited
the reduction in the binding of S100A8/A9 to the cells,
we checked whether the inhibitor inhibits the apoptosis-
inducing activity of S100A8/A9. Figure 6c shows that
sodium azide did indeed inhibit apoptosis. The addition
of sodium azide at 1h brought about a similar degree
of inhibition, whereas at 3h apoptosis was not inhibited.2005:5 (2005) Calprotectin Binding to Tumor Cells 289
These results raise the possibility that extensive ATP syn-
thesis after 3h is not necessary to induce apoptosis, and
that internalization of S100A8/A9 in the cells up to 3h is
adequate for the apoptosis.
Heparansulfateisnotinvolvedininductionof
apoptosisbyS100A8/A9
It was reported that S100A8/A9 binds heparan sul-
fate on endothelial cells in a zinc-dependent manner [23].
Since heparan sulfate is the universal component on cell
membranes of various kinds of cells [31], it is important
todetermineifbindingofS100A8/A9toheparansulfateis
necessary for the induction of apoptosis. For this, we ﬁrst
measured the binding to MM46 cells treated with hep-
arinase I or trypsin. The binding of 10µM S100A8/A9 to
the cells in the divalent cation-depleted medium or the
standard medium (conditions under which S100A8/A9
induces apoptosis) was not attenuated by heparinase I
treatment, but markedly attenuated by trypsin treatment
(Figure7a).Onthe otherhand, the binding of S100A8/A9
in the presence of 20µM zinc sulfate was moderately at-
tenuated in the heparinase I-treated cells, although it was
more extensively attenuated by trypsin treatment.
The eﬀect of heparan sulfate on S100A8/A9-induced
apoptosis was studied. Heparin reportedly binds S100A8/
A9 in the presence of zinc and inhibits the binding of the
protein complex to heparan sulfate on endothelial cells
[23]. Sodium heparin (40–200µM) did not inhibit apop-
tosis induced by 10µM S100A8/A9 either in the diva-
lent cation-depleted medium or in the standard medium
(data not shown). These results suggest that the binding
of S100A8/A9 to heparan sulfate is not involved in the in-
duction of apoptosis.
DISCUSSION
We previously reported that S100A8/A9 induced
apoptosis of EL-4 cells through the exclusion of extra-
cellular zinc [22]. Recent studies have described that
S100A8/A9 is able to kill not only cells that are sensi-
tive to zinc exclusion by a membrane impermeable zinc
chelator, DTPA, but also cells resistant to zinc depriva-
tion by DTPA, suggesting that S100A8/A9 induces apop-
tosis via dual mechanisms: a zinc exclusion-dependent
mechanism and possibly a receptor-dependent mecha-
nism [28]. S100A8/A9-induced death of DTPA-resistant
cell lines such as MM46 mammary tumor cells provides
evidence in support of the latter mechanism.
We showed that DTPA reduced the intracellular zinc
concentration in both EL-4 and MM46 cells to the same
extent as a membrane-permeable zinc chelator, TPEN.
However, most MM46 cells survived in the presence of
DTPA on day 1 and half were still alive on day 2. Since
almost all of the EL-4 cells undergo apoptosis on day
2w i t hD T P A[ 22], MM46 cells are clearly more resis-
tant to deprivation of intracellular zinc. This implies
that S100A8/A9 induced apoptosis of MM46 cells via a
mechanism other than zinc exclusion. This hypothesis is
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Figure 7. Binding of S100A8/A9 complex to MM46 cells which
were treated with trypsin or heparinase. Untreated MM46 cells
(thin dotted line) or cells treated with trypsin (bold dotted line),
or heparinase (bold line) were incubated with 5µM S100A8/A9
in the deﬁned divalent cation medium (a), in the standard
medium (b), or in the standard medium with 20µM zinc sul-
fate (c) for 1h, respectively. The histograms of the control cells
which were incubated without any sample for 1h in the respec-
tive medium are represented by a narrow solid line (solid line).
The amount of S100A8/A9 bound to the cells was measured as
described in “materials and methods.”
supported by the observation that S100A8 and S100A9
alone, despite having signiﬁcant zinc-binding capacity,
showed weaker cell death-inducing activity against EL-4
cells [22], but they were entirely ineﬀective against MM46
cells. This prompted the exploration of the capacity of
S100A8/A9 to bind to MM46 cells.290 Yuichi Nakatani et al 2005:5 (2005)
S100A8 and S100A9 homodimers as well as the
S100A8/A9 heterodimer were found to eﬀectively bind to
MM46 cells. However, the site of binding on MM46 cells
is not known. We note that there are several reports deal-
ing with the binding molecules for S100A8/A9 on cell
membrane: S100A8/A9 reportedly binds to heparan sul-
fateproteoglycan[23]orcarboxylatedglycans[24]o ne n-
dothelial cells. S100A8/A9 and arachidonic acid complex
reportedly interact with CD36 [25]. Furthermore, it was
also proposed that a receptor for advanced glycation end
products (RAGE) on macrophages and other cells might
be a universal receptor for the S100 protein family [26].
Among these molecules, heparan sulfate proteogly-
can is widely distributed on various cell types [31], and
it was reported that the binding of S100A8/A9 to hep-
aran sulfate or heparin depends on the presence of zinc
[23]. In this paper, we also found that the amount of
cell-bound S100A8/A9 in the divalent cation-depleted
medium was smaller than that in the standard medium,
andthattheformerincreasedproportionatelywiththein-
creaseinthezincconcentration.Examinationofthebind-
ing of S100A8/A9 to heparan sulfate on the cell mem-
brane showed that the induction of apoptosis of MM46
cells by S100A8/A9 is not mediated by the binding to hep-
aransulfate,sincebindingwaslittleaﬀectedbyheparinase
treatment of the target cells, and the apoptosis-inducing
activity was not inhibited in the presence of a high con-
centration of heparin. In these conditions, the binding
of S100A8/A9 was largely attenuated by the prior treat-
ment of the cells with trypsin, suggesting that the binding
molecule on the cells has a protein-like nature. The iden-
tiﬁcationoftheS100A8/A9“receptor”onMM46,orother
tumor cells, is the next important problem to be solved.
In our experiments, the binding of S100A8/A9 to
MM46 cells in the presence of excess zinc, was dimin-
ished signiﬁcantly by treatment with heparinase. Thus,
heparan sulfate appears to play a part in the binding of
S100A8/A9 in zinc-rich environments. S100A8, S100A9,
andS100A8/A9reportedlyshowsomebiologicalactivities
at low concentrations, conditions under which the zinc
concentrationsurpassestheconcentrationoftheproteins.
For example, cellular activities of S100A8/A9 include
chemotactic activity against inﬂammatory cells [15], and
S100A9 has been shown to have growth-stimulating ac-
tivity against ﬁbroblasts [32]. In addition, S100A8/A9 pu-
riﬁed from rat inﬂammatory neutrophils at low concen-
tration has an enhancing eﬀect on 3H-thymidine incor-
poration into human dermal ﬁbroblasts, but at higher
concentrations, induces apoptosis [18]. These observa-
tions suggest that zinc alters the biological activities of
S100A8/A9, presumably by modulating its aﬃnity for
binding molecules/receptors on target cells.
Underphysiologicalconditions suchasinﬂammation,
it can be postulated that S100A8/A9 induces growth of ﬁ-
broblasts to repair tissue damage at low concentrations.
Butasexpressionlevelsriseabovethecellularlevelsoffree
zincunderconditionsofsevereinﬂammation,S100A8/A9
will suppress tissue repair by inducing apoptosis of the
surrounding cells. Clearly, additional studies are needed
to test and reﬁne this hypothesis.
We found that a greater amount of S100A8/A9 was
required for the induction of apoptosis in the standard
medium than in the divalent cation-depleted medium. It
is therefore possible that the zinc-free form of S100A8/A9
induces apoptosis by binding a molecule distinct from the
zinc-bound S100A8/A9. However, it is diﬃcult to prove
whether the binding seen in the divalent cation-depleted
medium represents the binding of the zinc-free form of
S100A8/A9 because some S100A8/A9 molecules may be
capable of utilizing zinc ions from other cells. Alterna-
tively, the internalization of S100A8/A9 into an intracel-
lular compartment might be important for the induction
of apoptosis, for the following three reasons. (1) It was
observed that the amount of S100A8/A9 bound to the
cell surface at 1h incubation was decreased at 3h, but
the decrease was inhibited by zinc or sodium azide. (2)
S100A8/A9, at least in part, seems to be internalized and
degraded by lysosomes, because chloroquine increased
the amount of the cell-associated protein complex. (3)
Sodium azide presents throughout the assay inhibited
apoptosis, but when added at 3h, no inhibitory eﬀect on
apoptosis was detected. We previously reported that the
induction of apoptosis of MM46 cells by S100A8/A9 is
divided into an induction phase and an execution phase
[30]. In the later execution phase, the generation of re-
active oxygen species from about 8h after the start of in-
cubation is essential. It is therefore probable that sodium
azide does not interfere with the execution phase, but
rather interferes with the internalization of S100A8/A9
detected up to 3h during the induction phase. However,
other possible explanations cannot be ruled out, since the
eﬀect of sodium azide as an energy metabolism inhibitor
is very broad.
In summary, previous studies have shown that
S100A8/A9 can induce apoptosis in certain cell lines via
its high aﬃnity binding of zinc, causing depletion of zinc
incells.However,S100A8/A9iscapableofinducingapop-
tosis in cell lines such as MM46, which are not sensitive to
exclusion of intracellular zinc. We have obtained evidence
supporting the proposal that in these cells, an alternate
mechanism of S100A8/A9-induced apoptosis is operative,
involvingbindingtocellsurface“receptors.”Moreover,we
have shown that the binding of cells is in turn modulated
by the level of zinc, suggesting that the binding to cells by
Zn-bound S100A8/A9 is diﬀerent from the Zn-free state.
The elucidation of the target binding sites at the cell sur-
face should greatly enhance our insight into the mech-
anism underlying S100A8/A9-induced apoptosis and its
modulation by zinc.
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